Enhanced biopharmaceutical performance of brick dust molecule nilotinib via stabilized amorphous nanosuspension using a facile acid–base neutralization approach
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmaceutical Science
Link
https://link.springer.com/content/pdf/10.1007/s13346-023-01334-7.pdf
Reference51 articles.
1. European Medicines Agency (EMA). Assessment report for Tasigna (nilotinib) procedure No.: EMEA/H/C/000798/X/0028. 2010. p. 41.
2. Shukla S, Skoumbourdis AP, Walsh MJ, Hartz AMS, Fung KL, Wu C, et al. Synthesis and characterization of a BODIPY conjugate of the BCR-ABL kinase inhibitor Tasigna (nilotinib): evidence for transport of Tasigna and its fluorescent derivative by ABC drug transporters. Mol Pharm. 2011;8:1292–302.
3. Boons CCLM, den Hartog YM, Janssen JJWM, Zandvliet AS, Vos RM, Swart EL, et al. Food-effect study of nilotinib in chronic myeloid leukaemia (NiFo study): enabling dose reduction and relief of treatment burden. Eur J Haematol. 2020;105:148–55.
4. Mahon FX, Hayette S, Lagarde V, Belloc F, Turcq B, Nicolini F, et al. Evidence that resistance to nilotinib may be due to BCR-ABL, Pgp, or Src kinase overexpression. Can Res. 2008;68:9809–16.
5. Jesson G, Brisander M, Andersson P, Demirbüker M, Derand H, Lennernäs H, et al. Carbon dioxide-mediated generation of hybrid nanoparticles for improved bioavailability of protein kinase inhibitors. AAPS Pharm Res. 2014;31:694–705.
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Drug Nanocrystals in Oral Absorption: Factors That Influence Pharmacokinetics;Pharmaceutics;2024-08-29
2. Carboxymethyl cellulose-based rotigotine nanocrystals-loaded hydrogel for increased transdermal delivery with alleviated skin irritation;Carbohydrate Polymers;2024-08
3. Playing Hide-and-Seek with Tyrosine Kinase Inhibitors: Can We Overcome Administration Challenges?;The AAPS Journal;2024-06-11
4. Synergistic effect of polymers in stabilizing amorphous pretomanid through high drug loaded amorphous solid dispersion;Drug Delivery and Translational Research;2024-06-05
5. Combination of co-amorphization with SNEDDS outperforms Ofev® in the oral absorption of nintedanib;International Journal of Pharmaceutics;2024-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3